For the diagnosis of MASH, the AUROC curves for serum GP73 in participants with MASLD was 0.83, and for the identification of liver fibrosis stage F ≥ 2, the sensitivity and specificity were optimal (Table 1). Here, GOLM1 is linked to metabolic dysfunction-associated steatohepatitis.